FURTHER READING Theunissen , F.J., Chinery , L. and Pujar , Y.V. Current research on carbetocin and implications for prevention of postpartum haemorrhage. Reprod Health 2018: 15 ( Suppl 1): 94 FIGO recommendations on the management of postpartum hemorrhage . 2022. Int J Gynecol Obstet. 2022;157(Suppl. 1):3–50 Gungorduuk K, Asicioglu O, Besimoglu B, Guungorduuk OC, Yildirm G, Ark C, et al. Using intraumbilical v.ein injection of oxytocin in routine practice with active management of the third stage of labor : a randomized controlled trial. Obstet Gynecol. 2010 Sep. 116(3):619-24 WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with postpartum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389(10084): 2105– 16. Nguyen Toan Tran, Catrin Schulte- Hillen , Sarah Bar- Zeev , Agnes Chidanyika , Willibald Zeck . How to use heat-stable carbetocin and tranexamic acid for the prevention and treatment of postpartum haemorrhage in low-resource settings. BMJ Global Health 2022;7:e008913 World Health Organization. Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage. 2017. Haleema Shakur-Still, Ian Roberts, Stanislas Grassin-Delyle , Rizwana Chaudhri , Amber Geer, Monica Arribas , Elodie Lamy , Raoul Mansukhani , Mwansa Ketty Lubeya , Kiran Javaid et al. Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN- PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births. BJOG. 2023;00:1-10